Back to results

CompletedPhase 4

Pharmacology of Adjuvant Hormonotherapy in Breast Cancer

NCT01127295

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Clinique Calabet

Agen, France

+23 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2010-06-17
Enrollment: 2,000 participants
Sponsor: Institut Claudius Regaud
Purpose: treatment

Locations (24)

Clinique CalabetAgen, France
Clinique Claude BernardAlbi, France
Centre Hospitalier d'AuchAuch, France
CHU de BordeauxBordeaux, France
Clinique TivoliBordeaux, France
Institut BergoniéBordeaux, France
Polyclinique Bordeaux NordBordeaux, France
Centre Hospitalier de BriveBrive-la-Gaillarde, France
Centre Hospitalier de CahorsCahors, France
Centre Hospitalier Intercommunal de Castres-MazametCastres, France
Hôpital Dupuytren CHU LimogesLimoges, France
Centre Hospitalier de Mont de MarsanMont-de-Marsan, France
Centre Hospitalier de MontaubanMontauban, France
Centre Val d'AurelleMontpellier, France
Hôpital Caremeau CHU NîmesNîmes, France
Centre Hospitalier de PauPau, France
Centre Catalan d'OncologiePerpignan, France
Centre Hospitalier de RodezRodez, France
Polyclinique de l'OrmeauTarbes, France
Claudius RegaudToulouse, France
CHU de RangueilToulouse, France
Clinique Pasteur - Département d'Oncologie MédicaleToulouse, France
Clinique Pasteur - Département de RadiothérapieToulouse, France
Clinique Saint-Jean du LanguedocToulouse, France

Pharmacology of Adjuvant Hormonotherapy in Breast Cancer — TrialFind